Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
批准号:
8433483
负责人:
JOHN C HERR
金额:
$21.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-15 至 2015-01-31
关键词:
3-DimensionalAttentionBindingBiological AssayCatalytic DomainCellsCentrosomeContraceptive AgentsCrystallizationCustomDevelopmentDissectionDrug DesignDrug InteractionsEnzymesEventGenesGoalsHumanIn VitroKnowledgeLeadLibrariesLigandsMale ContraceptionsMale Contraceptive AgentsMale InfertilityMammalian CellMature CentrioleMeiosisMusOrganic SynthesisPathway interactionsPeptidesPharmaceutical PreparationsPhasePhosphotransferasesPlasmidsProductionProtein-Serine-Threonine KinasesProteinsResearchRoleSignal TransductionSiteSolidSperm MotilitySpermatidsSpermatogenesisSpermiogenesisStagingStructural ProteinStructureSubstrate InteractionTechnologyTestisbasecombinatorialcontraceptive targetenzyme structureimprovedin vivoinhibitor/antagonistkinase inhibitorprogramspromoterscreeningselective expressionsmall moleculesperm cellthree dimensional structure
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The testis specific serine threonine kinases 1 & 2 [TSSK 1 & 2] are closely related genes that have recently been validated as male contraceptive targets. These proteins are expressed selectively in the testis in post-meiotic spermatids. Deletion of TSSK 1 & 2 in mice causes male infertility, with arrest of spermiogenesis occurring during flagellogenesis. The TSSK 1 & 2 substrate, TSKS, localizes in both humans and mice to the centrosomes of spermatids during flagellogenesis and TSKS persists in the centrioles of mature spermatozoa. TSSK2 phosphorylates a second flagellar substrate, the sperm axonemal central apparatus protein SPAG16L. Deficiency of SPAG16L causes male infertility associated with impaired sperm motility, These key findings substantiate an indispensable role for TSSK 1 & 2 and the TSSK 1 & 2 pathway in spermatogenesis, providing the primary evidence for this study's central hypothesis: that administration of a small molecule inhibitor of TSSK 1 & 2 will result in male infertility by acting to impair flagellogenesis and sperm motility. In the proposed research two aims will be undertaken toward the goal of identifying a lead inhibitor of TSSK 1 & 2. Aim 1 will determine the three dimensional structures of human TSSK 1 & 2 and TSKS. In addition, structures of co-crystals of TSSK 1 & 2 with substrate, peptide, and drug ligands will be obtained. In Aim 2, compounds interacting with TSSK 1 & 2 will be identified through standard structure-function analysis, organic syntheses and combinatorial library screening. Attention will be directed to catalytic site, regulatory site and substrate inhibitors. We have built a custom combinatorial library based upon proprietary technology provided by GlaxoSmithKline and will screen this library to identify compounds that inhibit TSSK 1 & 2. This library was specifically developed to contain kinase inhibitors and will be screened by both solid phase and cell based assays. This research program will yield new information concerning events of signal transduction during spermiogenesis in humans and is predicted to identify compounds with contraceptive potential that selectively act on post-meiotic stages of spermatogenesis by inhibiting sperm flagellar formation and function.
PUBLIC RELEVANCE: This project will determine the crystal structures of 2 kinase enzymes [TSSK 1 & 2] and their substrate [TSKS] that are located in the human testis. The project will use the protein structural knowledge to identify compounds that bind to these kinase enzymes. TSSK 1 & 2 and TSKS are found in the testis in the last step of sperm production and have been shown in mice to be essential for proper sperm development and function Compounds that inhibit these kinases are anticipated to act as male contraceptive.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Recombinant production of enzymatically active male contraceptive drug target hTSSK2 - Localization of the TSKS domain phosphorylated by TSSK2.
酶活性男性避孕药物靶点 hTSSK2 的重组生产 - TSSK2 磷酸化的 TSKS 结构域的定位。
DOI:
10.1016/j.pep.2016.01.009
发表时间:
2016
期刊:
Protein expression and purification
影响因子:
1.6
作者:
[Shetty,Jagathpala, Sinville,Rondedrick, Shumilin,IgorA, Minor,Wladek, Zhang,Jianhai, Hawkinson,JonE, Georg,GundaI, Flickinger,CharlesJ, Herr,JohnC]
通讯作者:
Herr,JohnC
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
-
批准号:7770849
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2009
-
负责人:JOHN C HERR
-
依托单位:
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
-
批准号:8235939
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2009
-
负责人:JOHN C HERR
-
依托单位:
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
-
批准号:7842389
-
项目类别:
-
资助金额:$4.63万
-
财政年份:2009
-
负责人:JOHN C HERR
-
依托单位:
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
-
批准号:8049752
-
项目类别:
-
资助金额:$23.45万
-
财政年份:2009
-
负责人:JOHN C HERR
-
依托单位:
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
-
批准号:7626131
-
项目类别:
-
资助金额:$24.54万
-
财政年份:2009
-
负责人:JOHN C HERR
-
依托单位:
IMMUNODOMINANT OVARIAN ANTIGENS INVOLVED IN PREMATURE OVARIAN FAILURE
-
批准号:7231552
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2007
-
负责人:JOHN C HERR
-
依托单位:
Antimicrobial Proteins Secreted by the Epididymis
-
批准号:7420887
-
项目类别:
-
资助金额:$25.51万
-
财政年份:2004
-
负责人:JOHN C HERR
-
依托单位:
Antimicrobial Proteins Secreted by the Epididymis
-
批准号:7009566
-
项目类别:
-
资助金额:$26.8万
-
财政年份:2004
-
负责人:JOHN C HERR
-
依托单位:
Antimicrobial Proteins Secreted by the Epididymis
-
批准号:7176045
-
项目类别:
-
资助金额:$26.03万
-
财政年份:2004
-
负责人:JOHN C HERR
-
依托单位:
PROTEIN IMMUNOGENS OF THE HUMAN SPERM SURFACE
-
批准号:6316695
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2000
-
负责人:JOHN C HERR
-
依托单位:
PROTEIN IMMUNOGENS OF THE HUMAN SPERM SURFACE
-
批准号:6108643
-
项目类别:
-
资助金额:$27.0万
-
财政年份:1999
-
负责人:JOHN C HERR
-
依托单位:
CENTER FOR RECOMBINANT GAMETE CONTRACEPTIVE VACCINOGENS
-
批准号:6219728
-
项目类别:
-
资助金额:$7.46万
-
财政年份:1999
-
负责人:JOHN C HERR
-
依托单位:
IMMUNOLOGIC MECHANISMS IN HUMAN FEMALE INFERTILITY
-
批准号:6182527
-
项目类别:
-
资助金额:$30.13万
-
财政年份:1998
-
负责人:JOHN C HERR
-
依托单位:
PROTEIN IMMUNOGENS OF THE HUMAN SPERM SURFACE
-
批准号:6272241
-
项目类别:
-
资助金额:$23.71万
-
财政年份:1998
-
负责人:JOHN C HERR
-
依托单位:
IMMUNOLOGIC MECHANISMS IN HUMAN FEMALE INFERTILITY
-
批准号:2696577
-
项目类别:
-
资助金额:$22.24万
-
财政年份:1998
-
负责人:JOHN C HERR
-
依托单位:
IMMUNOLOGIC MECHANISMS IN HUMAN FEMALE INFERTILITY
-
批准号:2889378
-
项目类别:
-
资助金额:$25.45万
-
财政年份:1998
-
负责人:JOHN C HERR
-
依托单位:
IMMUNOLOGIC MECHANISMS IN HUMAN FEMALE INFERTILITY
-
批准号:6292654
-
项目类别:
-
资助金额:$4.32万
-
财政年份:1998
-
负责人:JOHN C HERR
-
依托单位:
IMMUNOLOGIC MECHANISMS IN HUMAN FEMALE INFERTILITY
-
批准号:6526323
-
项目类别:
-
资助金额:$35.38万
-
财政年份:1998
-
负责人:JOHN C HERR
-
依托单位:
IMMUNOLOGIC MECHANISMS IN HUMAN FEMALE INFERTILITY
-
批准号:6387866
-
项目类别:
-
资助金额:$30.88万
-
财政年份:1998
-
负责人:JOHN C HERR
-
依托单位:
PROTEIN IMMUNOGENS OF THE HUMAN SPERM SURFACE
-
批准号:6241161
-
项目类别:
-
资助金额:$23.3万
-
财政年份:1997
-
负责人:JOHN C HERR
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: